Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 34,351 | 31,117 | 64,018 | 49,499 | 27,792 |
| Operating Income | -34,351 | -31,117 | -64,018 | -49,499 | -27,792 |
| Other Income | 1,569 | 1,504 | 1,520 | 1,787 | 1,610 |
| Pre-tax Income | -32,782 | -29,613 | -62,498 | -47,712 | -26,182 |
| Net Income Continuous | -32,782 | -29,613 | -62,498 | -47,712 | -26,182 |
| Net Income | $-32,782 | $-29,613 | $-62,498 | $-47,712 | $-26,182 |
| EPS Basic Total Ops | 0.30 | -0.31 | -1.61 | -0.61 | 0.41 |
| EPS Basic Continuous Ops | -0.32 | -0.33 | -0.80 | -0.61 | -0.41 |
| EPS Diluted Total Ops | 0.30 | -0.31 | -1.61 | -0.61 | 0.41 |
| EPS Diluted Continuous Ops | -0.32 | -0.33 | -0.80 | -0.61 | -0.41 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.31 | -0.73 | -0.61 | -0.41 |
| EBITDA(a) | $-34,634 | $-31,133 | $-64,088 | $-49,736 | $-28,166 |